Bumrungrad Hospital Public - BUHPF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$6.06
+0 (0.00%)

This chart shows the closing price for BUHPF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bumrungrad Hospital Public Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BUHPF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BUHPF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Bumrungrad Hospital Public in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $6.06.

This chart shows the closing price for BUHPF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Bumrungrad Hospital Public. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/30/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/28/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/23/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/22/2023MacquarieInitiated CoverageOutperform
(Data available from 2/21/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/24/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/23/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/23/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/21/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Bumrungrad Hospital Public

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy centers, arrhythmia centers, behavioral health centers, breast centers, breastfeeding clinics, home service centers, clinics yangon, COVID-19 recovery clinics, heart valve centers, robotic surgery centers, spine institute, rehabilitation centers, children's (pediatrics) centers, colorectal surgery centers, complex coronary artery intervention centers, comprehensive sleep clinics, cornea transplant centers, dental centers, diagnostic centers, diagnostic radiology and nuclear medicine, dialysis centers, digestive disease centers, ear, nose and throat centers, emergency centers, endocrinology, diabetes and clinical nutrition centers, esperance, expatriate liaison centers, eye centers, fertility centers and IVF clinics, gastrointestinal motility centers, health screening centers, hearing and balance clinics, heart institute, holistic wound care centers, horizon regional cancer centers, hyperbaric oxygen therapy centers, intensive care unit, and medical clinics. The company also operates memory clinics, nephrology centers, neurocritical care, neuroscience centers, new life healthy aging clinics, nutrition services, orthopedic centers, parkinson's disease and movement disorders clinics, perinatal centers, pharmacy services, plastic (cosmetic) surgery centers, preventive genomics and integrative medicine, pride clinics, pulmonary (lung) centers, refractive surgery centers, robotic scoliosis centers, skin (dermatology) centers, sports medicine & joint centers, surgery clinics and surgery centers, travel medicine centers, urology centers, vaccine clinics, scientific wellness centers, vitallife skin and aesthetic centers, and women's centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.
Read More

Today's Range

Now: $6.06
Low: $6.06
High: $6.06

50 Day Range

MA: $6.08
Low: $6.06
High: $6.52

52 Week Range

Now: $6.06
Low: $6.06
High: $6.21

Volume

N/A

Average Volume

650 shs

Market Capitalization

N/A

P/E Ratio

1.97

Dividend Yield

1.15%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Bumrungrad Hospital Public?

The following Wall Street analysts have issued stock ratings on Bumrungrad Hospital Public in the last year: Macquarie.
View the latest analyst ratings for BUHPF.

What is the current price target for Bumrungrad Hospital Public?

0 Wall Street analysts have set twelve-month price targets for Bumrungrad Hospital Public in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Bumrungrad Hospital Public in the next year.
View the latest price targets for BUHPF.

What is the current consensus analyst rating for Bumrungrad Hospital Public?

Bumrungrad Hospital Public currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BUHPF will outperform the market and that investors should add to their positions of Bumrungrad Hospital Public.
View the latest ratings for BUHPF.

What other companies compete with Bumrungrad Hospital Public?

How do I contact Bumrungrad Hospital Public's investor relations team?

Bumrungrad Hospital Public's physical mailing address is 33 Sukhumvit Soi 3 (Nana Nua), Sukhumvit Road Klongtoey Nua Sub District Wattana Distric, Bangkok 10110, Thailand. The company's listed phone number is 66-2-066-8888. The official website for Bumrungrad Hospital Public is www.bumrungrad.com. Learn More about contacing Bumrungrad Hospital Public investor relations.